WOODSTOCK CORP

Position in EYPT — EyePoint, Inc.

CIK 1008877 BOSTON, MA

Position in EYPT

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$979,049

+$96,536 QoQ

Shares Held

68,465

0.0% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

WOODSTOCK CORP holds $23,238,186 across 10 Biotechnology names. EYPT ranks #4 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	20,518	$12,793,793
2	LGND	Ligand Pharmaceuticals Inc	18,345	$5,798,671
3	VRTX	Vertex Pharmaceuticals Inc / Ma	4,005	$1,989,403
4	EYPT	EyePoint, Inc. This page	68,465	$979,049
5	ALDX	Aldeyra Therapeutics, Inc.	242,756	$517,070
6	BMRN	Biomarin Pharmaceutical Inc	8,176	$467,830
7	RARE	Ultragenyx Pharmaceutical Inc.	9,191	$306,887
8	DRTS	Alpha Tau Medical Ltd.	20,609	$259,261

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$979,049	68,465	0.0%	Shares	Sole	2026-07-13
2026-03-31	$882,513	68,465	0.0%	Shares	Sole	2026-04-08
2025-12-31	$1,250,855	68,465	0.0%	Shares	Sole	2026-01-14
2025-09-30	$974,941	68,465	0.0%	Shares	Sole	2025-10-07
2025-06-30	$644,255	68,465	-4.2%	Shares	Sole	2025-07-09
2025-03-31	$387,421	71,480	0.0%	Shares	Sole	2025-04-09
2024-12-31	$532,526	71,480	0.0%	Shares	Sole	2025-01-15
2024-09-30	$571,125	71,480	+29.1%	Shares	Sole	2024-10-11
2024-06-30	$481,866	55,387	+80.0%	Shares	Sole	2024-07-08
2024-03-31	$636,181	30,778	+38.3%	Shares	Sole	2024-04-09
2023-12-31	$514,266	22,253	—	Shares	Sole	2024-01-08
No filing history on record for this holder in this stock.